The Herceptin part of the new drug homes in on cancer cells, sparing other healthy cells, and delivers DM1 into the cell. Experimental drug offers new way to battle certain breast cancer Breast cancer is the second leading cause of cancer-related deaths among women, according to the National Cancer Institute and the U.S. Centers for Disease Control and Prevention. Kadcyla, known as an "antibody-drug conjugate," represents "a completely new way" to treat HER2 positive metastatic breast cancer, said Dr. Hal Barron, chief medical officer and head of global product development for Genentech. -- A drug that presents a new way to knock out cancer cells was approved Friday to treat patients with a certain type of late-stage metastatic breast cancer. It's found in increased amounts on some types of cancer cells.